These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 17873678

  • 1. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P, Patkar AA, Peindl K, Murray HW, Wu LT, Hubbard R.
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [Abstract] [Full Text] [Related]

  • 2. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [Abstract] [Full Text] [Related]

  • 3. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.
    Stella L, D'Ambra C, Mazzeo F, Capuano A, Del Franco F, Avolio A, Ambrosino F.
    Life Sci; 2005 Oct 07; 77(21):2717-22. PubMed ID: 15979652
    [Abstract] [Full Text] [Related]

  • 4. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL.
    Lancet; 2011 Apr 30; 377(9776):1506-13. PubMed ID: 21529928
    [Abstract] [Full Text] [Related]

  • 5. Cost and utilization outcomes of opioid-dependence treatments.
    Baser O, Chalk M, Fiellin DA, Gastfriend DR.
    Am J Manag Care; 2011 Jun 30; 17 Suppl 8():S235-48. PubMed ID: 21761950
    [Abstract] [Full Text] [Related]

  • 6. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
    Gish EC, Miller JL, Honey BL, Johnson PN.
    Ann Pharmacother; 2010 Feb 30; 44(2):343-51. PubMed ID: 20040696
    [Abstract] [Full Text] [Related]

  • 7. Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.
    Davison JW, Sweeney ML, Bush KR, Davis Correale TM, Calsyn DA, Reoux JP, Sloan KL, Kivlahan DR.
    J Addict Dis; 2006 Feb 30; 25(4):27-35. PubMed ID: 17088223
    [Abstract] [Full Text] [Related]

  • 8. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J, Gossop M, Beswick T, Best D, Bearn J, Rees S, Strang J.
    Drug Alcohol Depend; 2007 Apr 17; 88(1):91-5. PubMed ID: 17064857
    [Abstract] [Full Text] [Related]

  • 9. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.
    Am J Drug Alcohol Abuse; 2006 Apr 17; 32(4):503-17. PubMed ID: 17127538
    [Abstract] [Full Text] [Related]

  • 10. Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
    Mannelli P, Wu LT, Peindl KS, Swartz MS, Woody GE.
    Drug Alcohol Depend; 2014 May 01; 138():83-8. PubMed ID: 24602363
    [Abstract] [Full Text] [Related]

  • 11. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
    Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL.
    Addiction; 2013 Sep 01; 108(9):1628-37. PubMed ID: 23701526
    [Abstract] [Full Text] [Related]

  • 12. The place of detoxification in treatment of opioid dependence.
    Gowing LR, Ali RL.
    Curr Opin Psychiatry; 2006 May 01; 19(3):266-70. PubMed ID: 16612211
    [Abstract] [Full Text] [Related]

  • 13. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L, Ali R, White JM.
    Cochrane Database Syst Rev; 2017 May 29; 5(5):CD002021. PubMed ID: 28553701
    [Abstract] [Full Text] [Related]

  • 14. Outpatient opiate detoxification with clonidine.
    Washton AM, Resnick RB.
    J Clin Psychiatry; 1982 Jun 29; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [Abstract] [Full Text] [Related]

  • 15. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG, Deden AL, Kerkhof AJ, Vorsteveld JP, van den Brink W.
    Ned Tijdschr Geneeskd; 1997 Dec 06; 141(49):2377-80. PubMed ID: 9554156
    [Abstract] [Full Text] [Related]

  • 16. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
    Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK.
    Alcohol Clin Exp Res; 2001 Nov 06; 25(11):1634-47. PubMed ID: 11707638
    [Abstract] [Full Text] [Related]

  • 17. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED, Kleber HD, Whittington RA, Heitler NE.
    JAMA; 2005 Aug 24; 294(8):903-13. PubMed ID: 16118380
    [Abstract] [Full Text] [Related]

  • 18. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
    Azatian A, Papiasvilli A, Joseph H.
    J Addict Dis; 1994 Aug 24; 13(1):35-52. PubMed ID: 8018739
    [Abstract] [Full Text] [Related]

  • 19. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G, Avanzini P, Rustichelli P, Passeri M.
    J Subst Abuse Treat; 1995 Aug 24; 12(1):35-41. PubMed ID: 7752296
    [Abstract] [Full Text] [Related]

  • 20. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N, Klein S, Kaube H, Kienbaum P, Peters J, Gastpar M.
    Pharmacopsychiatry; 1998 Nov 24; 31(6):205-9. PubMed ID: 9930633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.